{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:51:02Z","timestamp":1776286262963,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,24]]},"DOI":"10.7759\/cureus.86680","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T19:56:50Z","timestamp":1750795010000},"source":"Crossref","is-referenced-by-count":1,"title":["Clinicohematological Spectrum of Chronic Myeloid Leukemia: A Cross-Sectional Study From a Tertiary Care Hospital in North India"],"prefix":"10.7759","author":[{"given":"Sarah","family":"Arnestina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph M","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198810133191506","article-title":"The molecular genetics of Philadelphia chromosome-positive leukemias","volume":"319","author":"Kurzrock R","year":"1988","unstructured":"Kurzrock R, Gutterman JU, Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med. 1988, 319:990-8. 10.1056\/NEJM198810133191506","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.9.1399","article-title":"The P190, P210, and P230 forms of the BCR\/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity","volume":"189","author":"Li S","year":"1999","unstructured":"Li S, Ilaria RL Jr, Million RP, Daley GQ, Van Etten RA. The P190, P210, and P230 forms of the BCR\/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med. 1999, 189:1399-412. 10.1084\/jem.189.9.1399","journal-title":"J Exp Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25306","article-title":"Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic-phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY","volume":"94","author":"Hehlmann R","year":"2019","unstructured":"Hehlmann R, Cortes JE, Zyczynski T, et al.. Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic-phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY. Am J Hematol. 2019, 94:46-54. 10.1002\/ajh.25306","journal-title":"Am J Hematol"},{"key":"ref4","article-title":"Chronic myeloid leukemia in India: a review","volume":"5","author":"Bhutani N","year":"2020","unstructured":"Bhutani N. Chronic myeloid leukemia in India: a review. International Journal of Science and Healthcare Research. 2020, 5:6-11.","journal-title":"International Journal of Science and Healthcare Research"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5851.89792","article-title":"Changing trends of chronic myeloid leukemia in greater Mumbai, India over a period of 30 years","volume":"32","author":"Dikshit RP","year":"2011","unstructured":"Dikshit RP, Nagrani R, Yeole B, Koyande S, Banawali S. Changing trends of chronic myeloid leukemia in greater Mumbai, India over a period of 30 years. Indian J Med Paediatr Oncol. 2011, 32:96-100. 10.4103\/0971-5851.89792","journal-title":"Indian J Med Paediatr Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2003.1.200","article-title":"Chronic myeloproliferative disorders","author":"Spivak JL","year":"2003","unstructured":"Spivak JL, Barosi G, Tognoni G, Barbui T, Finazzi G, Marchioli R, Marchetti M. Chronic myeloproliferative disorders. Hematology Am Soc Hematol Educ Program. 2003, 200-24. 10.1182\/asheducation-2003.1.200","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.2","article-title":"The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations","volume":"30","author":"Gianelli U","year":"2017","unstructured":"Gianelli U, Cattaneo D, Bossi A, et al.. The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations. Mod Pathol. 2017, 30:1043. 10.1038\/modpathol.2017.2","journal-title":"Mod Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404880","article-title":"Haematological malignancies in developing countries: is CML the commonest childhood leukaemia?","volume":"21","author":"Wechalekar AD","year":"2007","unstructured":"Wechalekar AD, Parande CM. Haematological malignancies in developing countries: is CML the commonest childhood leukaemia?. Leukemia. 2007, 21:2194; author reply 2195. 10.1038\/sj.leu.2404880","journal-title":"Leukemia"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V88.7.2410.bloodjournal8872410","article-title":"Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR\/ABL with C3\/A2 junction)","volume":"88","author":"Pane F","year":"1996","unstructured":"Pane F, Frigeri F, Sindona M, et al.. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR\/ABL with C3\/A2 junction). Blood. 1996, 88:2410-4.","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.015271","article-title":"Tyrosine kinase inhibitor therapy can cure chronic myeloid leukemia without hitting leukemic stem cells","volume":"95","author":"Lenaerts T","year":"2010","unstructured":"Lenaerts T, Pacheco JM, Traulsen A, Dingli D. Tyrosine kinase inhibitor therapy can cure chronic myeloid leukemia without hitting leukemic stem cells. Haematologica. 2010, 95:900-7. 10.3324\/haematol.2009.015271","journal-title":"Haematologica"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5851.123728","article-title":"A short report on chronic myeloid leukemia from Post Graduate Institute of Medical Education and Research, Chandigarh","volume":"34","author":"Malhotra P","year":"2013","unstructured":"Malhotra P, Varma N, Varma S. A short report on chronic myeloid leukemia from Post Graduate Institute of Medical Education and Research, Chandigarh. Indian J Med Paediatr Oncol. 2013, 34:186-8. 10.4103\/0971-5851.123728","journal-title":"Indian J Med Paediatr Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05747-3","article-title":"Cytogenetic and epidemiological profile of chronic myeloid leukemia in Morocco","volume":"103","author":"Benchikh S","year":"2024","unstructured":"Benchikh S, Charl\u00e8ne SS, Bousfiha A, et al.. Cytogenetic and epidemiological profile of chronic myeloid leukemia in Morocco. Ann Hematol. 2024, 103:2765-74. 10.1007\/s00277-024-05747-3","journal-title":"Ann Hematol"},{"key":"ref13","article-title":"Clinico-pathological features and outcomes in chronic phase chronic myeloid leukemia patients treated with hydroxyurea","volume":"10","author":"Irfan SM","year":"2009","unstructured":"Irfan SM, Bhurgri Y. Clinico-pathological features and outcomes in chronic phase chronic myeloid leukemia patients treated with hydroxyurea. Asian Pac J Cancer Prev. 2009, 10:591-4.","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5851.123721","article-title":"Report of chronic myeloid leukemia in chronic phase from Eastern India, Institute of Hematology and Transfusion Medicine, Kolkata, 2001-2009","volume":"34","author":"Ray SS","year":"2013","unstructured":"Ray SS, Chakraborty P, Chaudhuri U, Ganesh. Report of chronic myeloid leukemia in chronic phase from Eastern India, Institute of Hematology and Transfusion Medicine, Kolkata, 2001-2009. Indian J Med Paediatr Oncol. 2013, 34:175-6. 10.4103\/0971-5851.123721","journal-title":"Indian J Med Paediatr Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011573","article-title":"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia","volume":"346","author":"Kantarjian H","year":"2002","unstructured":"Kantarjian H, Sawyers C, Hochhaus A, et al.. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med. 2002, 346:645-52. 10.1056\/NEJMoa011573","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O'Brien SG","year":"2003","unstructured":"O'Brien SG, Guilhot F, Larson RA, et al.. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med. 2003, 348:994-1004. 10.1056\/NEJMoa022457","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.270","article-title":"Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study","volume":"30","author":"Hochhaus A","year":"2015","unstructured":"Hochhaus A, Hellmann A, Pellegrino A, et al.. Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study. Leukemia. 2015, 30:57. 10.1038\/leu.2015.270","journal-title":"Leukemia"},{"key":"ref18","article-title":"Presentating phases of chronic myeloid leukaemia","volume":"19","author":"Ahmed R","year":"2009","unstructured":"Ahmed R, Naqi N, Hussain I, Khattak BK, Nadeem M, Iqbal J. Presentating phases of chronic myeloid leukaemia. J Coll Physicians Surg Pak. 2009, 19:469-72.","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5916.93423","article-title":"Cytogenetic & molecular analyses in adult chronic myelogenous leukaemia patients in north India","volume":"135","author":"Anand MS","year":"2012","unstructured":"Anand MS, Varma N, Varma S, Rana KS, Malhotra P. Cytogenetic & molecular analyses in adult chronic myelogenous leukaemia patients in north India. Indian J Med Res. 2012, 135:42-8. 10.4103\/0971-5916.93423","journal-title":"Indian J Med Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/359823-clinicohematological-spectrum-of-chronic-myeloid-leukemia-a-cross-sectional-study-from-a-tertiary-care-hospital-in-north-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T19:56:51Z","timestamp":1750795011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/359823-clinicohematological-spectrum-of-chronic-myeloid-leukemia-a-cross-sectional-study-from-a-tertiary-care-hospital-in-north-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.86680","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,24]]}}}